Leveraging electronic health records to examine differential clinical outcomes in people with Alzheimer's Disease
Venkatesh, S.; Wang, L.; Morris, M.; Moro, M.; Srivastava, R.; Han, Y.; Patira, R.; Berman, S. B.; Lopez, O.; Visweswaran, S.; Cai, T.; Cai, T.; Xia, Z.
Show abstract
BACKGROUNDAlzheimers disease (AD) carries a high societal burden inequitably distributed across demographic groups. OBJECTIVETo examine demographic differences and drivers of AD decline using real-world electronic health record (EHR) data with accurate AD population identification. METHODSLeveraging EHR data (1994-2022) from two large independent healthcare systems, we applied a novel unsupervised phenotyping algorithm to predict AD diagnosis and validated using gold-standard chart-reviewed and registry-derived diagnosis labels. Among patients with [≥]24 months of EHR data not living in nursing homes pre-AD diagnosis, we performed healthcare system-specific competing risk survival analyses to estimate the time to two readily ascertainable AD decline outcomes (i.e., nursing home admission, death), stratified by demographic groups and accounting for baseline covariates (e.g., age, gender, race, ethnicity, healthcare utilization, and comorbidities). We then performed a covariate-adjusted fixed-effects meta-analysis using inverse variance weighting to estimate the time to AD decline stratified by demographic groups. RESULTSThe algorithm achieved robust prediction in identifying AD patients across both healthcare systems (AUROC score range: 0.835-0.923) and demographic groups. Of the 29,262 AD patients in both healthcare systems (61% women, 90% non-Hispanic White, 79.52{+/-}9.39 years of age at AD diagnosis), 49% entered nursing homes and 48% died during follow-up. In covariate-adjusted fixed-effects meta-analysis, women had a higher risk of nursing home admission (HR[95% CI]=1.061[1.024-1.100], p=.001) and lower risk of death (HR[95% CI]=0.856[0.811-0.904], p<.0001) than men. Non-Hispanic White individuals had similar nursing home risk (HR[95% CI]=1.006[0.952-1.063], p=0.831) but higher death risk (HR[95% CI]=1.376[1.245-1.521], p<.0001) than racial and ethnic minorities. Older age at AD diagnosis and greater pre-existing comorbidity burden increased both nursing home admission and death risk. CONCLUSIONFindings from two large EHR cohorts add to the real-world evidence of demographic differences in clinical AD decline and its drivers, which could potentially inform individual clinical management and future public health policies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer’s Disease and Related Dementias 94%
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 92%
- Real-world datasets for the International Registry for Alzheimer’s Disease and Other Dementias (InRAD) and other registries: an international consensus 92%
Similar papers in this journal
- Machine Learning Prediction of Incidence of Alzheimers Disease Using Large-Scale Administrative Health Data 95%
- Interpretable deep learning approach for extracting cognitive features from hand-drawn images of intersecting pentagons in older adults 92%
- A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer’s disease 92%
Similar papers in this journal
- Frequency of Variants in Mendelian Alzheimer’s Disease Genes within the Alzheimer’s Disease Sequencing Project (ADSP) 94%
- A Qualitative Study of People with Alzheimer’s Disease in a Memory Clinic Considering Lecanemab Treatment 91%
- Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease 91%